Filitra, which contains Vardenafil as its active ingredient, is a medication used to treat erectile dysfunction (ED). It works by improving blood flow to the penis, which is crucial for achieving and maintaining an erection. Here’s a detailed look at how Filitra impacts blood flow to enhance erectile function:
Inhibition of PDE5: Filitra is a phosphodiesterase type 5 (PDE5) inhibitor. PDE5 is an enzyme that breaks down cyclic GMP (cGMP), a molecule that plays a key role in relaxing smooth muscle and dilating blood vessels. By inhibiting PDE5,
Filitra helps to maintain higher levels of cGMP.
Increased cGMP Levels: Elevated levels of cGMP lead to the relaxation of smooth muscle tissue in the blood vessels of the penis. This relaxation allows the blood vessels to widen (vasodilation), increasing blood flow to the penis.
Enhanced Erection: With increased blood flow, the penis fills with blood more effectively, leading to a firm and sustained erection in response to sexual stimulation. This helps to overcome the symptoms of ED.
Rapid Onset: Filitra typically starts working within 30 to 60 minutes of ingestion, allowing for timely sexual activity. Its onset can be affected by factors like food intake, but it generally provides a reliable and effective solution for managing ED.
Duration of Action: The effects of Filitra can last for about 4 to 5 hours, which allows for a window of opportunity for sexual activity. This duration helps in planning intimate encounters without the pressure of immediate action.
Improved Erection Quality: By increasing blood flow and sustaining it, Filitra helps achieve a more consistent and reliable erection. This can enhance sexual performance and satisfaction for both partners.